Back to Search Start Over

Protective effect of an improved immunization practice of mother-to-infant transmission of hepatitis B virus and risk factors associated with immunoprophylaxis failure

Authors :
Ke-Qin Hu
Jie Li
Chuan Wang
Junqi Niu
Simin Wen
Jing Jiang
Fei Kong
Xing Wu
Zhi-Fang Jia
Chong Wang
Source :
Wang, C; Wang, C; Jia, ZF; Wu, X; Wen, SM; Kong, F; et al.(2016). Protective effect of an improved immunization practice of mother-To-infant transmission of hepatitis B virus and risk factors associated with immunoprophylaxis failure. Medicine (United States), 95(34). doi: 10.1097/MD.0000000000004390. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/2d57p8md, Medicine
Publication Year :
2016
Publisher :
Ovid Technologies (Wolters Kluwer Health), 2016.

Abstract

Supplemental Digital Content is available in the text<br />Although routine immunoprophylaxis has been known to reduce hepatitis B virus (HBV) transmission, immunoprophylaxis failure still occurs. The study aimed to investigate the protective efficacy of an improved immunoprophylaxis protocol to prevent mother-to-infant transmission of HBV and to explore the potential risk factors associated with immunoprophylaxis failure and low antibody response. A prospective observational cohort study was conducted from July 2012 to April 2015. A total of 863 HBsAg-positive mothers and their 871 infants (8 pairs of twins) were included in the study. Two different hepatitis B vaccine doses (20 or 10 μg) were administered to the infants based on the hepatitis B e-antigen (HBeAg) status of their mothers. Simultaneously, hepatitis B immunoglobulin (HBIG) was administered to the infants. Initial injections of HBIG and the hepatitis vaccine were given within 2 hours after birth. Rates of HBV infections among the infants were evaluated at 7 months of age. Factors associated with immunoprophylaxis failure and low responses to vaccination were analyzed by unconditional logistic regression.. At 7 months of age, no immunoprophylaxis failure was observed in the 565 infants born to HBeAg-negative mothers. Among the 306 infants born to HBeAg-positive mothers, immunoprophylaxis failed in 16 infants (5.2%) of the infants and they were found to be HBsAg-positive. Further analysis showed that HBV DNA levels ≥108 IU/mL [odds ratio (OR) = 4.53, 95% confidence interval (95% CI): 1.19–17.34], delayed vaccination (OR = 4.14, 95% CI: 1.00–17.18), and inadequate initial injections (OR = 7.69, 95% CI: 1.71–34.59) were independently associated with immunoprophylaxis failure. Adequate titers of antibody to HBsAg (anti-HBs, ≥100 mIU/mL) were present in 96.5% of immunoprophylaxis-successful infants. For full-term infants, birth weights

Details

ISSN :
00257974
Volume :
95
Database :
OpenAIRE
Journal :
Medicine
Accession number :
edsair.doi.dedup.....879140bc171a8e9668d2ed695a412b84